Authors

The Future of GLP-1 Therapies: Hype, Evidence, and the Expanding Role of Pharmacists

In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Donald Langan, PharmD, MD, a Multiple Sclerosis and Clinical Neuroimmunology Fellow at Columbia University, presenting on the evolution of GLP-1 receptor agonists, discussed the future of GLP-1 therapies and the expansion of the pharmacist's role.

Pharmacist-Led BiTE Program at a Community Cancer Center

Cone Health Cancer Center pharmacists lead bispecific T-cell engager rollout, boosting local access to care.

Op-Ed: FTC Adds Fuel to the Fire for PBMs. Will Congress Deliver Real Reform?

The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board for a different approach.

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.

Promising Phase 2 and 3 Influenza Therapies: What Pharmacists Should Know

Explore emerging flu antivirals, from season-long CD388 prevention to single-dose therapies, designed to beat current treatment limits.

Could VER-01 Redefine the Role of Cannabis in Chronic Pain Care?

In an interview with Pharmacy Times, Erin J. Walsh, PharmD, RPh, MS, MCST, discusses how VER-01 could reshape the role of cannabis-derived medicines in chronic pain care, the evolving role of pharmacists, and why pharmaceutical cannabinoids and whole-plant cannabis should be viewed as complementary therapeutic options rather than competitors.

Real-World Evidence Helps Accelerate Formulary Decisions for Biologics

Pharmacist Interventions Impact Bottom Line in a Neurology Clinic

Neurology pharmacists drive safer medication changes, boost access and financial assistance, and deliver major cost savings through high-impact outpatient pharmacist intervention.

Depression May Be an Early Manifestation of Neurodegenerative Changes Leading to Movement Disorders

Recent research links depression to increased risk of Lewy body dementia and Parkinson disease, emphasizing the need for early detection and awareness.

Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists

These recommendations for acute pulmonary embolism management are most applicable to pharmacists on the interdisciplinary team managing acute PE.

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

Tenapanor offers a new approach to managing hyperphosphatemia in dialysis patients, balancing effectiveness with pill burden and cost considerations.

Op-Ed: Why Banning PBM-Owned Pharmacies Risks Patient Care

State policymakers should target bad actors while protecting access.

Beyond the Finish Line: Why the Pharmacy of Tomorrow is a Patient Journey, Not a Prescription Fill

With user expectations changing and the need to support patients throughout their entire treatment journey, growing technology-enabled communication allows pharmacists to build stronger relationships and go beyond prescription fill.

Halfway There Is Nowhere

A candid midlife reckoning in modern pharmacy care: Reclaim purpose, question the system, and reconnect work to meaning, patient impact, and wholehearted living.

The Role of the Pharmacist in the Management of Psychosis in Parkinson Disease

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Study: Maternal Asthma Increases Incidence of Adverse Perinatal Outcomes

Implementing Datopotamab Deruxtecan in Practice: TROPION Insights

Measles on the Move: Guidance for Pharmacists During Outbreaks

Between December 22, 2024, and March 7, 2025, reported measles cases in the US climbed precipitously.

New Jersey Society of Health-System Pharmacy Hosts 2nd Annual Pharmacy Leader and Pharmacy Technician Symposium

The NJSHP's 2nd Annual Symposium fosters networking and education for pharmacy professionals, featuring expert insights on compliance and regulation in pharmacy compounding.

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Beyond the Dispensing Counter: Community Service and Volunteerism Spur Growth

Volunteer service strengthens pharmacists’ empathy, confidence, and communication, boosting patient trust, teamwork, and community connection.

Type 2 Diabetes Medication Adherence Rates Remain Low—And Pharmacists Can Help

Adherence to glucose-lowering drugs ranges from 41% to 68% depending on drug class.

Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care Considerations

Atopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.

Advancing Anaphylaxis Treatment With Needle-Free Epinephrine Delivery

Intranasal epinephrine spray offers a needle-free option for anaphylaxis treatment.

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal Health

Cannabis use during pregnancy may harm fetal development and long-term health.

As Peptides Go Mainstream, USP <795> and <797> Matter More Than Ever

Peptide compounders face rising scrutiny as regulators and lawsuits zero in on adherence to established compounding standards.

Vaccination Conversations: Mastering Patient Q&A at the Pharmacy

When you’re unsure about answering a patient question, err on the side of caution and refer them to a pharmacist.